NR3C2 and metabolic syndrome: In people with insulin resistance, obesity, diabetes, dyslipidaemia or metabolic syndrome, several pathways can result in MR overactivation or ‘inappropriate’ MR activation, including changes in MR expression, and modulation of the MR by aldosterone and cortisol.37